CYP2F1
CYP2F1 is a gene that encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize aromatic and heterocyclic compounds.
Function[edit]
CYP2F1 is part of the cytochrome P450 family of enzymes, which are involved in the metabolism of a variety of substances. These enzymes are responsible for the oxidation of organic substances, which is a crucial step in the body's ability to break down and eliminate these substances.
CYP2F1, in particular, is known to metabolize aromatic and heterocyclic compounds. These types of compounds are often found in drugs and other xenobiotics, which are substances that are foreign to the body. By metabolizing these compounds, CYP2F1 plays a role in detoxifying these substances and making them easier for the body to eliminate.
Clinical significance[edit]
Alterations in the CYP2F1 gene can lead to changes in the function of the CYP2F1 enzyme, which can have significant clinical implications. For example, certain genetic variants of CYP2F1 have been associated with an increased risk of developing certain types of cancer, including lung cancer. This is likely due to the role of CYP2F1 in metabolizing carcinogens found in tobacco smoke.
In addition, certain drugs are metabolized by CYP2F1, and variations in this gene can affect how individuals respond to these drugs. For example, individuals with certain CYP2F1 variants may metabolize these drugs more quickly or more slowly than usual, which can affect the drug's efficacy and the risk of side effects.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian